Many of you have probably been aware of two prior World Health Organization (WHO) studies that showed almost twice the recovery rates from “schizophrenia” in developing countries as in developed countries. While critics of current psychiatric practice attributed the better outcome in developing countries to the fact that most were not on medication, others suggested that cultural factors were mostly responsible for the better outcomes.
A new study though, that looked only at people on medication in a wide variety of countries, found little difference in outcome between developing and developed countries. While not noted in the article, this apparently provides new backing for those who would maintain that it was the greater use of antipsychotic medication in developed countries that resulted in the greatly reduced recovery rates in those first two studies.
For those who want to know more about the assertion that long term use of antipsychotics is highly detrimental to real recovery and contributes to long term disability, this issue is covered in depth in Robert Whitaker’s new book, Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America